Talkspace Inc (TALK)
2.74
-0.06
(-2.14%)
USD |
NASDAQ |
May 17, 16:00
2.74
0.00 (0.00%)
Pre-Market: 20:00
Talkspace Research and Development Expense (Quarterly): 3.739M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.739M |
| December 31, 2023 | 3.867M |
| September 30, 2023 | 4.18M |
| June 30, 2023 | 4.171M |
| March 31, 2023 | 5.353M |
| December 31, 2022 | 4.79M |
| September 30, 2022 | 6.073M |
| June 30, 2022 | 5.576M |
| Date | Value |
|---|---|
| March 31, 2022 | 5.035M |
| December 31, 2021 | 3.896M |
| September 30, 2021 | 4.278M |
| June 30, 2021 | 4.781M |
| March 31, 2021 | 2.964M |
| December 31, 2020 | 2.256M |
| September 30, 2020 | 2.199M |
| June 30, 2020 | 2.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.199M
Minimum
Sep 2020
6.073M
Maximum
Sep 2022
4.097M
Average
4.176M
Median
Research and Development Expense (Quarterly) Benchmarks
| ModivCare Inc | -- |
| Marpai Inc | 0.007M |
| CVS Health Corp | -- |
| Teladoc Health Inc | 81.39M |
| Option Care Health Inc | -- |